• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Friday

    1/20/23 11:02:17 AM ET
    $ARQQ
    $BAX
    $BKD
    $CRON
    Computer Software: Prepackaged Software
    Technology
    Medical/Dental Instruments
    Health Care
    Get the next $ARQQ alert in real time by email

     

    Friday saw 23 companies set new 52-week lows.

    Significant Points From Today's 52-Week Lows:

    • L3Harris Technologies (NYSE:LHX) was the largest firm by market cap to set a new 52-week low.
    • The smallest company on a market cap basis to set a new 52-week low was Digital Brands Group (NASDAQ:DBGI).
    • Windtree Therapeutics (NASDAQ:WINT) saw the most pronounced move, as shares traded down 26.62% to hit its new 52-week low.
    • Arqit Quantum (NASDAQ:ARQQ) saw the biggest bounce back on, as shares traded up 0.0% to rebound after it hit its new 52-week low.

    Stocks that set new 52-week lows on Friday are as follows:

    • L3Harris Technologies (NYSE:LHX) stock set a new 52-week low of $190.11 on Friday, moving down 0.2%.
    • Hormel Foods (NYSE:HRL) stock hit $44.10 on Friday morning, setting a new 52-week low for a change of down 0.29%.
    • Baxter Intl (NYSE:BAX) stock hit a yearly low of $43.25. The stock was down 0.02% for the day.
    • Globant (NYSE:GLOB) stock dropped to a yearly low on Friday of $154.53. Shares traded down 0.11%.
    • National Fuel Gas (NYSE:NFG) stock dropped to a yearly low on Friday of $57.60. Shares traded down 0.95%.
    • Lumen Technologies (NYSE:LUMN) stock broke to a new 52-week low of $4.96 on Friday. Shares of the company traded up 1.62%.
    • Intellia Therapeutics (NASDAQ:NTLA) stock dropped to a yearly low on Friday of $32.44. Shares traded down 1.68%.
    • Granite Ridge Resources (NYSE:GRNT) stock broke to a new 52-week low of $7.83 on Friday. Shares of the company traded down 1.26%.
    • Cronos Group (NASDAQ:CRON) stock hit a new 52-week low of $2.39. The stock was down 0.62% on the session.
    • Skyward Specialty (NASDAQ:SKWD) stock hit $17.50 on Friday morning, setting a new 52-week low for a change of down 2.39%.
    • Brookdale Senior Living (NYSE:BKD) shares hit a yearly low of $2.37. The stock was up 1.86% on the session.
    • Domo (NASDAQ:DOMO) shares hit a yearly low of $11.35. The stock was down 9.87% on the session.
    • Arqit Quantum (NASDAQ:ARQQ) stock hit a yearly low of $2.02. The stock was 0.0% (flat) for the day.
    • KNOT Offshore Partners (NYSE:KNOP) stock broke to a new 52-week low of $5.54 on Friday. Shares of the company traded down 2.62%.
    • Rite Aid (NYSE:RAD) stock broke to a new 52-week low of $3.17 on Friday. Shares of the company traded up 1.88%.
    • FaZe Holdings (NASDAQ:FAZE) shares were down 7.96% for the day, having made a 52-week low of $0.92.
    • Lipella Pharmaceuticals (NASDAQ:LIPO) stock broke to a new 52-week low of $2.59 on Friday. Shares of the company traded up 1.51%.
    • Tricida (NASDAQ:TCDA) shares set a new 52-week low of $0.12. The stock traded down 3.82%.
    • Windtree Therapeutics (NASDAQ:WINT) shares were down 26.62% for the day, having made a 52-week low of $0.14.

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $ARQQ alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ARQQ
    $BAX
    $BKD
    $CRON

    CompanyDatePrice TargetRatingAnalyst
    Domo Inc.
    $DOMO
    2/13/2026$3.50Mkt Outperform → Mkt Underperform
    Citizens
    Lumen Technologies Inc.
    $LUMN
    2/4/2026Outperform → Mkt Perform
    Raymond James
    Cronos Group Inc.
    $CRON
    1/27/2026Buy
    Canaccord Genuity
    Globant S.A.
    $GLOB
    1/6/2026$72.00Hold
    Truist
    Brookdale Senior Living Inc.
    $BKD
    1/6/2026$13.00Underperform → Buy
    BofA Securities
    L3Harris Technologies Inc.
    $LHX
    12/16/2025$367.00Equal-Weight → Overweight
    Morgan Stanley
    L3Harris Technologies Inc.
    $LHX
    12/12/2025$331.00Buy
    Citigroup
    KNOT Offshore Partners LP
    $KNOP
    12/8/2025Buy → Neutral
    Alliance Global Partners
    More analyst ratings

    $ARQQ
    $BAX
    $BKD
    $CRON
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman and CEO Kubasik Christopher E converted options into 16,060 shares and covered exercise/tax liability with 5,993 shares, increasing direct ownership by 7% to 162,577 units (SEC Form 4)

    4 - L3HARRIS TECHNOLOGIES, INC. /DE/ (0000202058) (Issuer)

    2/26/26 7:39:14 PM ET
    $LHX
    Industrial Machinery/Components
    Industrials

    Pres., Coms. & Spec. Dom. Rambeau Jon converted options into 3,034 shares and covered exercise/tax liability with 790 shares, increasing direct ownership by 41% to 7,660 units (SEC Form 4)

    4 - L3HARRIS TECHNOLOGIES, INC. /DE/ (0000202058) (Issuer)

    2/26/26 7:31:13 PM ET
    $LHX
    Industrial Machinery/Components
    Industrials

    Vice President & CHRO Rakita Melanie converted options into 340 shares and covered exercise/tax liability with 83 shares, increasing direct ownership by 4% to 6,509 units (SEC Form 4)

    4 - L3HARRIS TECHNOLOGIES, INC. /DE/ (0000202058) (Issuer)

    2/26/26 7:30:52 PM ET
    $LHX
    Industrial Machinery/Components
    Industrials

    $ARQQ
    $BAX
    $BKD
    $CRON
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    October 18, 2024 - FDA Roundup: October 18, 2024

    For Immediate Release: October 18, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  This week, FDA continues ongoing efforts to increase access and supply of IV and peritoneal dialysis (PD) fluids following Hurricane Helene-related damage to Baxter International Inc.’s facility in Marion, North Carolina. Specifically, FDA acted quickly to c

    10/18/24 4:16:25 PM ET
    $NVCR
    $BAX
    Medical/Dental Instruments
    Health Care

    $ARQQ
    $BAX
    $BKD
    $CRON
    SEC Filings

    View All

    SEC Form 20-F filed by Globant S.A.

    20-F - Globant S.A. (0001557860) (Filer)

    2/27/26 5:04:41 PM ET
    $GLOB
    EDP Services
    Technology

    SEC Form S-8 filed by Intellia Therapeutics Inc.

    S-8 - Intellia Therapeutics, Inc. (0001652130) (Filer)

    2/26/26 5:31:47 PM ET
    $NTLA
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    SEC Form 6-K filed by Globant S.A.

    6-K - Globant S.A. (0001557860) (Filer)

    2/26/26 4:10:28 PM ET
    $GLOB
    EDP Services
    Technology

    $ARQQ
    $BAX
    $BKD
    $CRON
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Domo downgraded by Citizens with a new price target

    Citizens downgraded Domo from Mkt Outperform to Mkt Underperform and set a new price target of $3.50

    2/13/26 8:28:18 AM ET
    $DOMO
    Computer Software: Prepackaged Software
    Technology

    Lumen Technologies downgraded by Raymond James

    Raymond James downgraded Lumen Technologies from Outperform to Mkt Perform

    2/4/26 8:28:23 AM ET
    $LUMN
    Telecommunications Equipment
    Telecommunications

    Canaccord Genuity initiated coverage on Cronos Group

    Canaccord Genuity initiated coverage of Cronos Group with a rating of Buy

    1/27/26 9:29:20 AM ET
    $CRON
    Medicinal Chemicals and Botanical Products
    Health Care

    $ARQQ
    $BAX
    $BKD
    $CRON
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Secretary of War Pete Hegseth Visits L3Harris Solid Rocket Motor Site

    Secretary of War Pete Hegseth visited the L3Harris Technologies (NYSE:LHX) Camden site today as part of his nationwide "Arsenal of Freedom" tour, highlighting the importance of American manufacturing capacity in strengthening the defense industrial base and supporting U.S. and allied warfighters. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260227797011/en/Secretary of War Pete Hegseth addresses a crowd of approximately 1,500 L3Harris employees in Camden, Arkansas, as part of his "Arsenal of Freedom" tour. Secretary Hegseth toured several of the site's solid rocket motor production facilities and spoke with the 1,500 employees

    2/27/26 6:45:00 PM ET
    $LHX
    Industrial Machinery/Components
    Industrials

    Globant Files Annual Report for 2025

    LUXEMBOURG, Feb. 27, 2026 /PRNewswire/ -- Globant S.A. (NYSE:GLOB), a digitally native technology services company (the "Company"), announced today that it filed its annual report on Form 20-F for the year ended December 31, 2025 (the "2025 Annual Report") with the U.S. Securities and Exchange Commission ("SEC"). The 2025 Annual Report can be accessed by visiting either the SEC's website at www.sec.gov or the Company's website at http://investors.globant.com. In addition, shareholders may receive a hard copy of the Company's complete audited financial statements free of charge, by requesting a copy from: Globant S.A., 37A Avenue J.F. Kennedy, L-1855, Luxembourg.

    2/27/26 6:24:00 PM ET
    $GLOB
    EDP Services
    Technology

    Domo Announces Timing of its Fourth Quarter and Full-Year Fiscal 2026 Earnings Conference Call

    Domo (NASDAQ:DOMO) today announced that results for its fourth quarter and full-year fiscal 2026 (ended January 31, 2026) will be released on Tuesday, March 10, 2026, after market close. The company will host a conference call at 3:00 p.m. (MT) / 5:00 p.m. (ET) to discuss its financial results with the investment community. A live dial-in is available at (877) 484-6065 or (201) 689-8846. A live webcast of the event will also be available on the Domo Investor Relations website at www.domo.com/IR. A replay will be available at (877) 660-6853 or (201) 612-7415 with access ID# 13758775 following the completion of the conference call until 11:59 p.m. (ET) on April 10, 2026. About Domo Do

    2/27/26 9:00:00 AM ET
    $DOMO
    Computer Software: Prepackaged Software
    Technology

    $ARQQ
    $BAX
    $BKD
    $CRON
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President & CEO Johnson Kathleen E bought $499,925 worth of shares (78,685 units at $6.35), increasing direct ownership by 0.93% to 8,562,582 units (SEC Form 4)

    4 - Lumen Technologies, Inc. (0000018926) (Issuer)

    2/5/26 5:34:09 PM ET
    $LUMN
    Telecommunications Equipment
    Telecommunications

    Director Cohen Fred E bought $1,402,500 worth of shares (150,000 units at $9.35), increasing direct ownership by 261% to 207,453 units (SEC Form 4)

    4 - Intellia Therapeutics, Inc. (0001652130) (Issuer)

    1/7/26 4:05:06 PM ET
    $NTLA
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Director Chase William J bought $1,003,000 worth of shares (100,000 units at $10.03), increasing direct ownership by 288% to 134,693 units (SEC Form 4)

    4 - Intellia Therapeutics, Inc. (0001652130) (Issuer)

    8/22/25 4:30:14 PM ET
    $NTLA
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $ARQQ
    $BAX
    $BKD
    $CRON
    Leadership Updates

    Live Leadership Updates

    View All

    Hormel Foods Appoints Donald Monk as Company's First Chief Technology Officer

    New role underscores company's commitment to modernizing technology, digital and data capabilitiesAUSTIN, Minn., Feb. 24, 2026 /PRNewswire/ -- Hormel Foods Corporation (NYSE:HRL), a Fortune 500 global branded food company, today announced the appointment of Donald Monk as chief technology officer, effective March 23. In this newly created role, Monk will serve as the company's senior-most technology leader, responsible for envisioning, aligning and delivering the enterprise technology, digital and data strategy that supports long‑term growth. "Don is an exceptional technology le

    2/24/26 4:30:00 PM ET
    $HRL
    Meat/Poultry/Fish
    Consumer Staples

    Hormel Foods Names Will Bonifant Group Vice President and Chief Supply Chain Officer

    Seasoned supply chain leader to oversee global procurement, manufacturing, planning, logistics and engineering AUSTIN, Minn., Feb. 12, 2026 /PRNewswire/ -- Hormel Foods Corporation (NYSE:HRL), a Fortune 500 global branded food company, today announced the appointment of Will Bonifant as group vice president and chief supply chain officer, effective March 9. In this role, Bonifant will lead the company's global supply chain, including procurement, manufacturing, planning, logistics, engineering and supply chain innovation. "Will is a proven supply chain leader who has scaled co

    2/12/26 5:00:00 PM ET
    $HRL
    Meat/Poultry/Fish
    Consumer Staples

    Lumen Technologies Appoints Jeff Sharritts as Chief Revenue Officer

    Veteran leader to deepen customer relationships, sharpen execution, and scale company's commercial engine in Lumen's next phase of transformation Lumen Technologies (NYSE: LUMN) today announced that Jeff Sharritts has been appointed Executive Vice President and Chief Revenue Officer, effective Feb. 4, 2026. He will report to Lumen CEO Kate Johnson and will lead Lumen's commercial strategy, including the Acceleration and Growth Team, with a focus on deepening customer relationships and driving profitable growth for the company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260203640994/en/LUMN) as EVP and Chief Revenue Officer

    2/3/26 4:01:00 PM ET
    $LUMN
    Telecommunications Equipment
    Telecommunications

    $ARQQ
    $BAX
    $BKD
    $CRON
    Financials

    Live finance-specific insights

    View All

    Domo Announces Timing of its Fourth Quarter and Full-Year Fiscal 2026 Earnings Conference Call

    Domo (NASDAQ:DOMO) today announced that results for its fourth quarter and full-year fiscal 2026 (ended January 31, 2026) will be released on Tuesday, March 10, 2026, after market close. The company will host a conference call at 3:00 p.m. (MT) / 5:00 p.m. (ET) to discuss its financial results with the investment community. A live dial-in is available at (877) 484-6065 or (201) 689-8846. A live webcast of the event will also be available on the Domo Investor Relations website at www.domo.com/IR. A replay will be available at (877) 660-6853 or (201) 612-7415 with access ID# 13758775 following the completion of the conference call until 11:59 p.m. (ET) on April 10, 2026. About Domo Do

    2/27/26 9:00:00 AM ET
    $DOMO
    Computer Software: Prepackaged Software
    Technology

    Globant Reports 2025 Fourth Quarter Financial Results

    LUXEMBOURG, Feb. 26, 2026 /PRNewswire/ -- Globant (NYSE:GLOB) today announced results for the three and twelve months ended December 31, 2025. "Twenty-three years ago, we set out to build a company that would reinvent how technology gets created. Today, we are reinforcing that commitment. In 2025, we delivered our highest revenue and strongest free cash flow ever, while simultaneously transforming our entire delivery model. As the world shifts from experiment to implementation, our AI-native Pods present a new approach on how software is built and scaled. We are moving beyond th

    2/26/26 4:15:00 PM ET
    $GLOB
    EDP Services
    Technology

    Intellia Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results and Business Updates

    HAELO Phase 3 clinical data for lonvo-z in HAE expected by mid-2026; BLA submission in second half of 2026; anticipated U.S. launch in first half of 2027Process underway to reactivate global sites for MAGNITUDE-2 Phase 3 clinical trial of nex-z in ATTRv-PN; enrollment completion expected in second half of 2026FDA engagement ongoing to resolve clinical hold on MAGNITUDE Phase 3 clinical trial of nex-z in ATTR-CM Ended 2025 with approximately $605 million in cash, cash equivalents and marketable securities; expected to fund operations into the second half of 2027 CAMBRIDGE, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading biopharmaceutical com

    2/26/26 7:30:00 AM ET
    $NTLA
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $ARQQ
    $BAX
    $BKD
    $CRON
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Arqit Quantum Inc.

    SC 13D/A - Arqit Quantum Inc. (0001859690) (Subject)

    12/13/24 8:03:28 PM ET
    $ARQQ
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by Arqit Quantum Inc.

    SC 13D/A - Arqit Quantum Inc. (0001859690) (Subject)

    12/10/24 8:05:26 PM ET
    $ARQQ
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Windtree Therapeutics Inc.

    SC 13G/A - WINDTREE THERAPEUTICS INC /DE/ (0000946486) (Subject)

    11/14/24 7:15:44 PM ET
    $WINT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care